A simple, automated, nonextraction assay for serum digoxin using particle-enhanced immunoassay

Therapeutic Drug Monitoring

Volumn 19, Issue 1, 1997, Pages 108-111

  Davey, Carol L ^a   Thakkar, Hansa ^a   Newman, David J ^a   Price, Christopher P ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

Digoxin; Nonextraction; Particle enhanced immunoassay

Indexed keywords

DIGOXIN;

ACCURACY; ARTICLE; AUTOANALYSIS; CENTRIFUGAL ANALYZER; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG MONITORING; FLUORESCENCE POLARIZATION IMMUNOASSAY; PRIORITY JOURNAL;

CARDIOTONIC AGENTS; DIGOXIN; HUMANS; IMMUNOASSAY; LATEX; NEPHELOMETRY AND TURBIDIMETRY; REPRODUCIBILITY OF RESULTS;

EID: 0031427815     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007691-199702000-00021     Document Type: Article

References (14)

1. Hallworth M, Capps N. Individual drugs: digoxin. In: Therapeutic drug monitoring in clinical biochemistry. Cambridge: ACB Venture Publications, 1993:54-9.
2. Aronson JK, Hardman M. ABC of monitoring drug therapy: digoxin. Br Med J 1992;305:1149-52.
3. Ullman EF, Maggio ET. Principles of homogeneous enzyme-immunoassay. In: Maggio ET, ed. Enzyme immunoassay. Florida: CRC Press, 1980:105-34.
4. Dandliker WB, Kelly RJ, Dandliker J. Fluorescence polarisation immunoassay: theory and experimental methods. Immunochemistry 1973;10:219-27.
5. Henderson DR, Friedman SB, Harris JB, Manning WB, Zoccoli MA. CEDIA, a new homogeneous immunoassay system. Clin Chem 1986;32:1637-41.
6. Pudek MR, Seccombe DW, Jacobson BE, Humphries K. Effect of assay conditions on cross reactivity of digoxin-like immunoreactive substance(s) with radioimmunoassay kits. Clin Chem 1985; 31:1806-10.
7. Morris RG, Frewin DB, Saccoia NC, Goldsworthy WL, Jeffries WS, McPhee AJ. Interference from digoxin-like immunoreactive substance(s) in commercial digoxin kit assay methods. Eur J Clin Pharmacol 1990;39:359-63.
8. Galvin JP, Looney CE, Leflar CE, et al. Particle enhanced immunoassay systems. In: Nakamura RM. Ditto WR, Tucker ES, eds. Clinical laboratory assays: new technology and future directions. New York: Masson, 1983:73-95.
9. Newman DJ, Henneberry H, Price CP. Particle enhanced light-scattering immunoassay. Ann Clin Biochem 1992;29:22-42.
10. Deming WE. Statistical adjustment of data. New York: Wiley, 1943:184.
11. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;307-10.
12. Khanna P. Homogeneous enzyme immunoassay. In: Price CP, Newman DJ, eds. Principles and practice of immunoassay. London: Stockton Press, 1991:326-64.
13. Skogen WF, Rea MR, Valdes R. Endogenous digoxin-like immunoreactive factors eliminated from serum samples by hydrophobic silica-gel extraction and enzyme immunoassay. Clin Chem 1987:33:401-14.
14. Avendano C, Alvarez JS, Sacristan JA, et al. Interference of digoxin-like immunoreactive substances with TDX digoxin-II assay in different patients. Ther Drug Monit 1991;13:523-7.